Quilt Health, a digital health company, raises $6M in seed funding to improve treatment access for complex diseases.
The funding round was led by MaC Venture Capital and Underscore Ventures, with participation from other investors.
The company, initially focused on sickle cell disease, plans to expand into other hematologic, neurological, and cardiovascular disorders.
Quilt Health aims to modernize clinical trial access by integrating multiple data sources and applying AI to support clinical workflows.
Their platform benefits pharmaceutical sponsors by accelerating trial execution, reducing costs, and supporting patient diversity.
Research sites and clinicians gain access to enhanced tools and recruitment support, allowing them to focus on delivering quality care and research.
For patients, Quilt Health's platform improves care by keeping them connected with clinicians, making cutting-edge treatments more accessible.
Quilt Health partnered with the National Alliance of Sickle Cell Centers to create a more efficient patient-centered ecosystem combining research and patient care.
The funding will be used to accelerate product development, fuel R&D, expand the team, and target regions lacking life sciences investment.